No Picture
Trading Ideas

Oracle Is Said to Gain Advantage in Deal for TikTok in U.S.

(Bloomberg) — Oracle Corp.’s negotiations for TikTok’s U.S. operations have intensified in recent days in a sign that the software maker is gaining the upper hand over its main rival, Microsoft Corp., people with knowledge of the matter said.A decision could come in the next couple of days, one of the people said. Early offers from both parties valued the U.S. business at about $25 billion, but that was before Chinese officials weighed in with new rules imposing limits on technology exports, and the terms may have also changed, the people said, asking not to be identified as the information …read more […]

No Picture
Trading Ideas

Nvidia Buys SoftBank’s Arm for $40 Billion in Biggest Chip Deal

(Bloomberg) — Nvidia Corp. said it agreed to buy SoftBank Group Corp.’s chip division Arm Ltd. for $40 billion, taking control of some of the most widely used technology in electronics in the semiconductor industry’s largest-ever deal.Nvidia will pay $21.5 billion in stock and $12 billion in cash for the U.K. based-chip designer, including a $2 billion payment at signing. Softbank may receive an additional $5 billion cash or stock if Arm’s performance meets certain targets, the companies said Sunday in a statement. An additional $1.5 billion will be paid to Arm employees in Nvidia stock.The initial payment to SoftBank …read more […]

No Picture
Trading Ideas

U.S. Stock Futures Climb After Two-Week Slide: Markets Wrap

(Bloomberg) — U.S. equity futures pointed higher Monday as investors looked ahead to a Federal Reserve meeting that could provide clues on the policy outlook. Asian stocks looked set for a muted start.Futures were little changed in Japan and Australia, while S&P 500 contracts were up about 0.5%. Global stocks are coming off the back of the first consecutive weeks of declines since March. Currency markets saw muted moves as trading began Monday. Gold was steady and crude oil slipped.With the Fed expected this week to maintain its dovish stance on policy, investors will continue to look out for signs …read more […]

No Picture
Trading Ideas

Gilead's $21 Billion Deal Splurge May End in Regret

(Bloomberg Opinion) — Gilead Pharmaceuticals Inc. has faced the same problem for years: The drugmaker has a strong core business in its world-leading HIV franchise, but it hasn’t been able to consistently grow beyond that base the way it should. Against that backdrop, you’d think a more aggressive M&A strategy would be cause for celebration. The devil, as always, is in the details.Gilead’s $21 billion purchase of New Jersey-based biotechnology firm Immunomedics Inc. and its promising breast cancer drug Trodelvy, announced Sunday afternoon, certainly qualifies as a bold move. At $88 a share, the acquisition represents a more than 100% …read more […]

No Picture
Trading Ideas

10 Biggest Pharmaceutical Companies in the World in 2020

In a world dominated by a pandemic, you might wonder how its affecting the 10 biggest pharmaceutical companies in the world in 2020 (click to skip ahead and see the top 3 pharma companies). The pharmaceutical industry is a trillion dollar industry globally, achieving the milestone for the first time in 2014, and the biggest […] …read more […]

No Picture
Trading Ideas

Elon Musk's 2018 Compensation Plan May Hurt S&P 500 Inclusion

Shareholders of Tesla Inc. (NASDAQ: TSLA) approved a compensation plan for CEO Elon Musk back in 2018 that may complicate future inclusion in the S&P 500.What Happened: The Wall Street Journal recently reported that Tesla could be disqualified for a long time from S&P 500 inclusion as the accounting of Musk’s payday hurts the company’s profits. Tesla shares have fallen after not being included in the S&P 500. Why It’s Important: The 2018 compensation plan tied Musk’s earnings to the performance of Tesla’s financials and stock performance. Musk is eligible for twelve payments tied to the market capitalization, revenue, and …read more […]

No Picture
Trading Ideas

Analysts: 3 Tech Stocks to Buy on Weakness

September has been anything but kind to tech stocks. After hitting a record high at the beginning of the month, fears that tech valuations had climbed too high crept into investors’ minds. As a result, tech stocks have been feeling the heat, with the NASDAQ down 10% since September 2. The index currently sits at 10,853.55, following its fifth decline in six sessions. While September is traditionally a volatile month for Wall Street, the upcoming presidential election, ongoing pandemic and flaring U.S.-China tensions are also weighing on investors. However, analysts remind investors that beaten-down doesn’t mean out, arguing the …read more […]

No Picture
Trading Ideas

AP EXPLAINS: Biden sizable but not radical tax plans

President Donald Trump describes Democratic challenger Joe Biden as a “tool” of “radical socialists” who are bent on taxing every American business and household into bankruptcy. In reality, Biden has taken a relative consistent approach over five decades in politics and during his latest White House bid. The former senator and vice president backs an active federal government that he says should support but not constrict private enterprise, and he believes the highest federal tax burden should fall on the wealthiest. …read more […]

No Picture
Trading Ideas

IPO Outlook For The Week: Snowflake and Amwell Lead Busy 12 IPO Lineup

Benzinga took a look at high profile IPOs coming in the second half of 2020. Six of those 13 companies could price the week of September 14. Here is a look at the 12 companies expected to go public.Amwell: Alphabet Inc. (NASDAQ: GOOG) backed Amwell (NYSE: AMWL) plans to sell 35 million shares in a range of $14 to $16. Amwell is a leading telehealth company that is a rival to Teladoc Health (NYSE: TDOC), a company who has seen its stock rise more than 130% in 2020. As part of the $100 million investment from Google, Amwell will switch …read more […]